I'll give you 4 reasons why this company is a dog and why investors would be smart to stay away:
1) 10-20% top line growth for a small cap is lame - period.
2) Earnings are even lamer - take a look at MDT as a $15B company that has $3B in earnings. On a normalized basis, MDT is doing almost 3x better.
3) The product line is boring and their R&D pipeline is non-existent.
4) Their acquistion strategy is a joke. They have no reall $$ to buy anything with any real value and they are too scared to take a risk. Dave Robert's comments on the current M&A market were lamer than that from a 1st year analyst. His head is way too big - both literally and figuratively - to do any real deals.
No matter how you slice it, lipstick only goes so far on a pig. And this one is a pig. Georgie Jr and friends pat themselves on the back for earning a profit for a $50M medical device company? My advice to you is to rethink your investment hypothesis unless you don't care about making money.
I got stuck in this pile of dog doo at $7 and can't get out.